According to GlobalData, ARK is one of 82 product lines sold in the US toxicology tests market; these product lines are sold by 31 different manufacturers. The average selling price for ARK increased in hospitals, health systems, and outside of hospital facilities in 2022. The price of the ARK device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
Smarter leaders trust GlobalData
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as ARK Diagnostics apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
ARK Diagnostics overview
ARK Diagnostics Inc (ARK Diagnostics) is a developer, manufacturer and commercializer of in vitro diagnostic immunoassay products. The company’s products include protease inhibitors, levetiracetam assay, topiramate assay, non-nucleoside reverse transcriptase inhibitors, gabapentin assay, lamotrigine assay, fentanyl assay, zonisamide assay, methotrexate assay, thyroxine assay, and entry inhibitor. Its products are used in the therapeutic areas of epilepsy, pain management, cancer, urine test, veterinary, and HIV or AIDS. ARK Diagnostics’ protease inhibitors include ritonavir, darunavir, saquinavir, amprenavir, lopinavir, atazanavir, indinavir and tipranavir. The company’s immunoassays measure drug levels in biological fluids that enable clinicians to guide dosing decisions for drug therapy. It distributes its products across Germany, Austria, Belgium, the Netherlands, Luxembourg, the UK and Ireland. ARK Diagnostics is headquartered in Fremont, California, the US.
For a complete picture of ARK, Toxicology Tests pricing in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
